全文获取类型
收费全文 | 1147篇 |
免费 | 54篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 116篇 |
妇产科学 | 13篇 |
基础医学 | 154篇 |
口腔科学 | 28篇 |
临床医学 | 98篇 |
内科学 | 292篇 |
皮肤病学 | 24篇 |
神经病学 | 31篇 |
特种医学 | 251篇 |
外科学 | 66篇 |
综合类 | 12篇 |
预防医学 | 38篇 |
眼科学 | 9篇 |
药学 | 31篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 7篇 |
2020年 | 3篇 |
2018年 | 13篇 |
2017年 | 11篇 |
2016年 | 7篇 |
2015年 | 11篇 |
2014年 | 21篇 |
2013年 | 22篇 |
2012年 | 24篇 |
2011年 | 15篇 |
2010年 | 40篇 |
2009年 | 50篇 |
2008年 | 36篇 |
2007年 | 34篇 |
2006年 | 34篇 |
2005年 | 23篇 |
2004年 | 27篇 |
2003年 | 21篇 |
2002年 | 24篇 |
2001年 | 24篇 |
2000年 | 15篇 |
1999年 | 32篇 |
1998年 | 52篇 |
1997年 | 72篇 |
1996年 | 57篇 |
1995年 | 43篇 |
1994年 | 52篇 |
1993年 | 54篇 |
1992年 | 14篇 |
1991年 | 18篇 |
1990年 | 15篇 |
1989年 | 39篇 |
1988年 | 42篇 |
1987年 | 35篇 |
1986年 | 29篇 |
1985年 | 29篇 |
1984年 | 11篇 |
1983年 | 26篇 |
1982年 | 17篇 |
1981年 | 18篇 |
1980年 | 21篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1975年 | 19篇 |
1966年 | 1篇 |
1948年 | 1篇 |
排序方式: 共有1205条查询结果,搜索用时 468 毫秒
61.
Baumgartner C; Morell A; Hirt A; Bucher U; Forster HK; Doran JE; Matter L; Brun del Re G; Wagner HP 《Blood》1988,71(5):1211-1217
Elimination of neoplastic B cell populations from autologous bone marrow grafts also removes normal B lymphocytes. This is potentially hazardous for the reconstitution of the immune system in patients undergoing high-dose chemotherapy and total body irradiation followed by autologous marrow rescue. Five pediatric patients with B cell non- Hodgkin's lymphoma in first remission undergoing such a regimen were studied. They received bone marrow pretreated with anti-Y 29/55 monoclonal antibody and complement. B and T lymphocyte subpopulations reached normal levels within 6 months after autologous bone marrow transplantation (ABMT), and serum immunoglobulin levels became normal within 4 to 9 months. Vaccination with diphtheria and tetanus toxoid, trivalent poliomyelitis vaccine of the Salk type, and pneumococcal capsular antigens (38 to 54 months after transplantation) gave rise to specific antibody production. ABO isoagglutinins could be demonstrated in all patients. The response pattern was similar to that of patients who received unmanipulated autologous bone marrow. It is concluded that ex vivo anti-Y 29/55 depletion of the marrow graft does not induce relevant disturbances of humoral immune functions. 相似文献
62.
幽门螺杆菌cagⅡ对胃上皮细胞IL-8基因转录的影响及机制 总被引:6,自引:0,他引:6
目的探讨HpcagⅡ对胃上皮细胞IL-8基因转录的影响及信号传导机制。方法构建
cagⅡ基因位点缺失Hp突变株及带有IL-8报告基因的人胃癌细胞系L5F11,用液体闪烁计数仪测定荧光素酶(IL8转录)活性,用ELISA法测定IL8蛋白浓度。结果所有Hp突变株诱导荧光素酶活性与IL8蛋白浓度较亲代菌株26695均降低[(0.13±0.01)×cpm比(0.59±0.05)×(P<0.01);(0.73±0.13)ng/ml比(2.22±0.65)ng/ml,(P<0.05)]。PTK抑制剂herbimycinA不仅抑制Hp诱导的荧光素酶活性[(0.71±0.18)×cpm比(1.51±0.23)×cpm,(P<0.05)],而且抑制IL-8蛋白表达[(0.83±0.41)ng/ml比(3.22±0.59)ng/ml,(P<0.05)],但herbimycinA对TNFα诱导的荧光素酶活性及IL8蛋白表达均无影响(P均>0.05);PKA抑制剂H7抑制TNFα诱导的荧光素酶活性[(0.74±0.16)×cpm比(2.62±0.26)×cpm,(P<0.001)]及IL8蛋白表达[(1.45±0.38)ng/ml比(4.12±0.43)ng/ml,(P<0.01)],而对Hp诱导的荧光素酶活性无影响(P>0.05)。结论HpcagⅡ中的多基因能够调节胃上皮细胞IL-8基因转录,且这一作用主要经蛋白酪氨酸激酶途径。 相似文献
63.
M. Pineda J.E. Wraith E. Mengel F. Sedel W.-L. Hwu M. Rohrbach B. Bembi M. Walterfang G.C. Korenke T. Marquardt C. Luzy R. Giorgino M.C. Patterson 《Molecular genetics and metabolism》2009,98(3):243-249
Miglustat has been shown to stabilize disease progression in children, juveniles and adults with Niemann-Pick disease type C (NP-C), a rare genetic disorder characterized by progressive neurological deterioration. We report findings from a retrospective observational cohort study assessing the effects of miglustat on neurological disease progression in patients treated in the clinical practice setting. Data from all NP-C patients prescribed miglustat at 25 expert centers were evaluated using a disease disability scale. The scale analyzed four key parameters of neurological disease progression in NP-C (ambulation, manipulation, language, swallowing). Mean individual parameter scores and a composite score were calculated at baseline (time of diagnosis) and up to 4 follow-up visits. Overall, 66 patients were included (mean [SD] age at diagnosis, 9.7 [7.6] years, and at treatment start, 12.8 [9.5] years). The median (range) miglustat exposure was 1.46 (0.05–4.51) years. Mean annual progression was +0.11 score units/year from diagnosis to treatment start, indicating disease progression prior to therapy, and decreasing to −0.01 score units/year from treatment start to last clinic visit, indicating stabilization. Stabilization of neurological disease on miglustat was observed in all age groups, but the magnitude of the effect was greater in patients diagnosed in late childhood and in juveniles and adults. Stabilization of neurological disease was also observed in a subset of 19 patients with extended pre-treatment information. Overall, these data support previous clinical trial findings indicating clinically relevant beneficial effects of miglustat on neurological disease progression in patients with NP-C. 相似文献
64.
Robert F. Wynn J. Ed Wraith Jean Mercer Karen Tylee Margaret Thornley Brian W. Bigger 《The Journal of pediatrics》2009,154(4):609-37524
65.
AC Winter K Berger JE Buring & T Kurth 《Cephalalgia : an international journal of headache》2009,29(2):269-278
We evaluated the association of body mass index (BMI) with migraine and migraine specifics in a cross-sectional study of 63 467 women aged ≥ 45 years, of whom 12 613 (19.9%) reported any history of migraine and 9195 had active migraine. Compared with women without migraine and a BMI < 23 kg/m2 , women with a BMI ≥ 35 kg/m2 had adjusted odds ratios (ORs) (95% confidence intervals) of 1.03 (0.95, 1.12) for any history of migraine. Findings were similar for active migraineurs. Women with a BMI of ≥ 35 kg/m2 had increased risk for low and high migraine frequency, with the highest estimate for women who reported daily migraine. Compared with women with the lowest associated risk (migraine frequency < 6 times/year; BMI between 27.0 and 29.9 kg/m2 ), women with a BMI ≥ 35 kg/m2 had an OR of daily migraine of 3.11 (1.12, 8.67). Among the women with active migraine, a BMI ≥ 35 kg/m2 was associated with increased risk of phonophobia and photophobia and decreased risk of a unilateral pain characteristic and migraine aura. Our data confirm previous findings that the association between BMI with migraine is limited to migraine frequency and specific migraine features. 相似文献
66.
In a retrospective study, clinical risk factors of the neonatal period were correlated with the severity of regressed retinopathy of prematurity (ROP) in a population of preterm infants (bw less than 1500 g and or gestational age less than 33 weeks). At the age of 5-11 years 134 out of 528 preterm born infants (25.4%) were found to be under ophthalmic care. Reliable information on eye fundus status could be obtained in 105 of them. Regressed ROP was found in 61, the moderate form in 48 (9.1%) and the severe form in 13 (2.5%) patients. Twelve patients (2.3%) had visual acuity of less than 0.3 on the worst eye and two (0.4%) of these patients were blind from ROP. Twenty-four clinical factors of the newborn period were correlated with the severity of regressed ROP. The results suggest that long oxygen exposure in combination with other factors interfering with retinal vasotonus are associated with the degree of the disease developed. 相似文献
67.
The mucopolysaccharidoses 总被引:1,自引:0,他引:1
The experience of the Royal Children's Hospital in managing patients with mucopolysaccharidosis is discussed. All share the common feature of abnormal storage, within lysosomes, of partially degraded glycosaminoglycans, but different diseases within the group as a whole present different problems. The presentation, diagnosis and clinical outcome of 69 affected children are described. 相似文献
68.
Martínez-Rodríguez J Iranzo A Santamaría J Genís D Molins A Silva Y Meléndez R 《Neurología (Barcelona, Spain)》2002,17(2):113-116
Introduction: Cataplexy is one of the main narcoleptic symptoms and is characterized by sudden loss of muscle tone triggered by emotional stimuli while consciousness is mantained. Clomipramine is an effective treatment of cataplexy. Cataplexy that occurs repeatedly for hours or days is referred to as status cataplecticus.Patients: We report three adults with narcolepsy in whom cataplexy was chronically and effectively treated with clomipramine (75-150 mg/day). For diverse reasons, these three patients had an abrupt withdrawal of clomipramine, and after 2-9 days patients showed an invalidant status cataplecticus characterized by a marked increase of the frequency, duration and severity of their cataplectic attacks that were now elicited by mild emotional stimuli. After introduction of anticataplectic agents (clomipramine in two patients and fluoxetine in one patient), status cataplecticus was resolved in less than a week.Conclusion: In patients with narcolepsy, abrupt withdrawal of chronic treatment with clomipramine may be associated with status cataplecticus. This condition may be resolved with the reintroduction of anticataplectic agents. 相似文献
69.
背景:阿德福韦双酯(ADV) 是一种有效治疗野生型和耐拉米夫定乙肝病毒(HBV)的核苷酸类药物。在使用核苷酸类药物治疗慢性乙肝时,当治疗时间为 48、96、144周时,耐ADV变异体出现的累积发生率分别为0、 0.8-3%和0-5.9%。目的:研究67例对拉米夫定耐药且接受ADV治疗的慢性乙肝患者耐ADV病毒变异体的表型和基因型特点。方法:HBV DNA含量采用实时定量PCR技术。ADV变异体检测采用基质辅助激光解吸电离/飞行时间质谱为基础的基因分型 相似文献
70.